Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Volumes of Intranasal Midazolam in Children
NCT01948908Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jun 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of midazolam in laceration (3 arms), sponsored by Columbia University. Primary endpoint: Median Time After Administration of Intranasal Midazolam Until Patient Achieves Minimal Sedation at 20 minutes. Started Jun 2013; status: completed.
02
Drugs
midazolam
03
Conditions
laceration
Beyond the preview
Go deeper on NCT01948908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01948908.